Hello Greenwave, love your work. Reading your post, I concluded you think Summit/Pfizer combo and other ADCs in NSCLC space have quite the probability of outshining EFTI/Keytruda and leaving us in their wake, dead in the water. Have I misinterpreted?
IMM Price at posting:
30.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)